Metastatic Breast Cancer

Carey K. Anders, MD, medical director for the Center for Brain and Spine Metastasis at Duke Cancer Institute, discussed treatment options for brain metastasis across breast cancer, including HER2-positive, triple-negative or hormone receptor-positive disease.

Rikki Cannioto, PhD, EdD, of Roswell Park Comprehensive Cancer Center, discussed her study linking physical activity before and after breast cancer treatment to reduced recurrence and mortality rates among patients with high-risk disease.